APGE

APGE Operating Cash Flow (Statement)

-$243.89MTTM · USD

Period ending:

APGE FY Cash from OperationsUSD
APGE FY Cash from Operations2022-12-31: -$16.43M2023-12-31: -$74.76M2024-12-31: -$171.17M2025-12-31: -$227.45M$0.00-$227.45M
2022-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

APGE operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 4 observations from Dec 31, 2022 to Dec 31, 2025.

Apogee Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-227,450,000
-171,174,000
-74,761,000
-16,427,000

Compare operating cash flow (statement)

All APGE financial metrics · APGE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.